We are committed to discovering new therapies that focus on novel mechanisms to regulate gene expression and protein synthesis. We recognize that targeted therapies have limitations in treating solid tumors, such as patient and tumor heterogeneity, acquired treatment resistance, broad side-effect profiles, and avoidance mechanisms limiting efficacy. Our goal is to address these challenges by leveraging our science and technology to develop new therapies that directly target the underlying mechanisms of disease.

We are building an innovative biotechnology company focused on treating cancer through regulation of interconnected genes that target tumor growth and survival. Our mission is to develop these innovative therapies and make them accessible to patients worldwide, regardless of their financial situation. We will achieve this by partnering with healthcare providers, regulatory agencies, and advocacy groups to ensure that our therapies are available to those who need them most.

By working together, we believe we can transform the cancer treatment landscape and improve the lives of millions of people affected by cancer. Join us in our mission to revolutionize the treatment of cancer and other intractable diseases.